Recursion Pharmaceuticals, Inc. (RXRX) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
RXRX Stock Price Trajectory (2021–2026)
As of February 28, 2026, Recursion Pharmaceuticals, Inc. (RXRX) trades at $3.67, representing a -51.1% return over the past year. The stock has delivered a -27.2% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $42.81 on July 13, 2021. From this peak, RXRX has corrected -91.4%, currently trading 25% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers REGN (+11.9% 1Y), CNTA (+72.7% 1Y), and IMNM (+132.6% 1Y), RXRX has underperformed the peer group average. Compare RXRX vs REGN →
Historical Price Data
Showing 30 of 1,225 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 3.66 | 3.72 | 3.57 | 3.67 | 3 | -2.65% |
| 2026-02-26 | 3.68 | 3.79 | 3.57 | 3.77 | 3 | 0.00% |
| 2026-02-25 | 3.91 | 4.08 | 3.75 | 3.77 | 3 | +6.80% |
| 2026-02-24 | 3.39 | 3.60 | 3.38 | 3.53 | 3 | +3.52% |
| 2026-02-23 | 3.39 | 3.56 | 3.33 | 3.41 | 3 | -0.29% |
| 2026-02-20 | 3.64 | 3.70 | 3.38 | 3.42 | 3 | -8.06% |
| 2026-02-19 | 3.46 | 3.73 | 3.44 | 3.72 | 20.24M | +5.38% |
| 2026-02-18 | 3.06 | 3.54 | 2.98 | 3.53 | 38.44M | +5.53% |
| 2026-02-17 | 3.48 | 3.49 | 3.34 | 3.35 | 4.18M | -4.15% |
| 2026-02-13 | 3.60 | 3.72 | 3.45 | 3.49 | 16.00M | -2.51% |
| 2026-02-12 | 3.74 | 3.75 | 3.49 | 3.58 | 18.91M | -3.50% |
| 2026-02-11 | 3.87 | 3.88 | 3.64 | 3.71 | 24.05M | -3.64% |
| 2026-02-10 | 4.00 | 4.09 | 3.84 | 3.85 | 11.08M | -3.27% |
| 2026-02-09 | 3.95 | 4.00 | 3.85 | 3.98 | 14.14M | 0.00% |
| 2026-02-06 | 3.74 | 4.02 | 3.69 | 3.98 | 26.17M | +11.80% |
| 2026-02-05 | 3.79 | 3.88 | 3.54 | 3.56 | 40.33M | -8.72% |
| 2026-02-04 | 4.12 | 4.13 | 3.71 | 3.90 | 36.72M | -4.88% |
| 2026-02-03 | 4.21 | 4.29 | 3.96 | 4.10 | 23.38M | -1.91% |
| 2026-02-02 | 4.12 | 4.26 | 4.08 | 4.18 | 17.40M | -0.24% |
| 2026-01-30 | 4.26 | 4.34 | 4.16 | 4.19 | 19.68M | -3.01% |
| 2026-01-29 | 4.44 | 4.48 | 4.30 | 4.32 | 17.32M | -3.36% |
| 2026-01-28 | 4.64 | 4.64 | 4.42 | 4.47 | 16.09M | -2.83% |
| 2026-01-27 | 4.64 | 4.74 | 4.49 | 4.60 | 15.64M | +0.22% |
| 2026-01-26 | 4.71 | 4.72 | 4.55 | 4.59 | 15.41M | -2.96% |
| 2026-01-24 | 4.90 | 4.96 | 4.70 | 4.73 | 18.16M | 0.00% |
| 2026-01-23 | 4.90 | 4.96 | 4.70 | 4.73 | 18.33M | -4.64% |
| 2026-01-22 | 4.65 | 5.24 | 4.62 | 4.96 | 36.31M | +7.59% |
| 2026-01-21 | 4.42 | 4.67 | 4.35 | 4.61 | 26.91M | +4.77% |
| 2026-01-20 | 4.46 | 4.55 | 4.39 | 4.40 | 22.17M | -5.78% |
| 2026-01-16 | 4.65 | 4.88 | 4.55 | 4.67 | 21.33M | +0.65% |
See RXRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RXRX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare RXRX vs AGIO
See how RXRX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has RXRX stock performed recently?
RXRX declined -51.1% over the past year, below its 5-year annualized CAGR of -27.2%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is RXRX's all-time high price?
Recursion Pharmaceuticals, Inc. reached $42.81 on 2021-07-13. The 52-week high is $7.89. Current 1-year return of -51.1% places the stock further from historical peaks.
Where can I download RXRX historical price data?
This page provides RXRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.